Mode
Text Size
Log in / Sign up
Phase 4 N=97 Double-blind Treatment

Effects of a Pectoralis Minor Muscle Stretching Protocol

Shoulder Pain

Enrolled (actual)
97
Serious AEs
48.4%
Results posted
Feb 2015
Primary outcome: Primary: Pectoralis Minor Length After Pectoralis Minor Stretching Protocol — 16.38; 16.87 centimeters — p=<0.05

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Stretching-Asymptomatic subjects (Procedure); Stretching-Subjects with shoulder pain (Procedure)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Universidade Federal de Sao Carlos
Primary completion
Aug 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Pectoralis Minor Length After Pectoralis Minor Stretching Protocol
16.38; 16.87 <0.05 sig
SECONDARY
Scapular Kinematics After Pectoralis Minor Stretching Protocol
30; 40 >0.05

Summary

The purpose of this study is to verify the effects of a stretching protocol for the pectoralis minor muscle on its resting length and on the 3D kinematics of the scapula during arm flexion in asymptomatic subjects and patients with impingement syndrome with shortened pectoralis minor.

Eligibility Criteria

Inclusion Criteria

Asymptomatic subjects were included if they did not have any positive test for SIS.

The subjects with shoulder pain were included if:

  • they had history of shoulder, at least one week;
  • 18 - 45 years;
  • range of motion > 150° evaluated with digital inclinometer;
  • one or more impingement tests positive - Neer (Neer, 1972), Hawkins (Hawkins and Kennedy, 1980) and Jobe (Jobe and Moynes, 1982) - associated with painful arc during arm elevation, or during external rotation with 90° of arm elevation;
  • Individuals from both groups also had to present with shortened PM muscle length.

Exclusion Criteria

Individuals from both groups were excluded if they:

  • BMI (body mass index) > 28kg/m2;
  • irradiated shoulder pain;
  • scoliosis;
  • history of shoulder pain with beginning traumatic;
  • history of fracture or surgery in upper limb and rotator cuff;
  • systemic illnesses;
  • tape allergy;
  • were pregnant;
  • physiotherapy at least 6 months.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01956240). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search